ABL, Inc. and CALIXAR Announced Strategic Marketing Agreement

ABL will extend the capabilities of its vaccine and biologics therapeutic development services by offering CALIXAR’s innovative process for native extraction and purification of membrane proteins and antigens that avoid the necessity of re